On 22 November 2024, the Victor Babeș University of Medicine and Pharmacy Timișoara, as Lead Partner, started the implementation of the project “Promoting resilience of health systems and equal access to skin and liver care through RORS screening and treatment solutions” (acronym HEPASKIN), in partnership with the General Hospital “Đorđe Jovanović” Zrenjanin. The project is implemented under ERDF subsidy contract no. 253819/18.11.2024, project code RORS00307, concluded with the Ministry of Public Works, Development and Administration of Romania, acting as Managing Authority of the Interreg IPA Romania-Serbia Programme.

Interreg VI-A IPA Romania–Serbia 2021–2027 · Priority 2 – Social and economic development · SO 2.2 – Ensuring equal access to healthcare and increasing the resilience of health systems.

The overall objective of the project is to ensure equal access to quality skin and liver cancer services in the cross-border area for 4,000 persons/patients. This is achieved by raising awareness, investing in high-tech equipment, developing screening capacity for 40 healthcare service providers through joint training activities, and implementing 2 registries, ultimately improving the health of the population in the cross-border area.

The project is co-funded by the European Union through the Interreg IPA Romania-Serbia Programme. The total project value is EUR 2,041,920.48, of which the total non-reimbursable financial assistance from IPA III CBC (Instrument for Pre-accession Assistance III 2021-2027) is EUR 1,735,632.40. The contribution from the national budget of Romania is EUR 194,777.52, and the eligible co-financing of the project partners is EUR 111,510.56. The implementation period is 24 months.